OTC · CIK 0001568385
BMTM Bright Mountain Media, Inc.
Insider trading from SEC Form 4. Last filing May 19, 2026.
Bright Mountain Media, Inc. (BMTM) has 11 SEC Form 4 filings on file from 7 insiders, the latest filed on May 19, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Bright Mountain Media, Inc., scored.
Transactions
Every row filed, 13 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | Ari Roy Olgun Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +1,000,000 | $0.00 | $0 | 1,000,000 | May 19, 2026 |
| Feb 26, 2026 | Thomas A. Triscari director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 3, 2026 |
| Jan 2, 2025 | Thomas A. Triscari director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 3, 2026 |
| Feb 26, 2026 | Elaine J. Riddell director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 2, 2026 |
| Feb 26, 2026 | Joseph Pergola director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 2, 2026 |
| Feb 26, 2026 | Jeffrey K. Hirsch director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 2, 2026 |
| Mar 7, 2025 | Ethan Rudin Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Mar 11, 2025 |
| Jan 2, 2025 | Joseph Pergola director | AGrant or award Stock Option (right to buyderivative | +100,000 | $0.00 | $0 | 100,000 | Mar 11, 2025 |
| Jan 2, 2025 | Elaine J. Riddell director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 11, 2025 |
| Mar 26, 2024 | Jeffrey K. Hirsch director | AGrant or award Common Stock | +38,082 | $0.00 | $0 | 38,082 | Mar 11, 2025 |
| Jan 1, 2024 | Jeffrey K. Hirsch director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 11, 2025 |
| Jan 2, 2025 | Jeffrey K. Hirsch director | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 11, 2025 |
| Nov 14, 2024 | Matthew Drinkwater Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Matthew DrinkwaterChief Executive Officer
- Jeffrey K. Hirschdirector
- Ari Roy OlgunChief Financial Officer
- Joseph Pergoladirector
- Elaine J. Riddelldirector
- Ethan RudinChief Financial Officer
- Thomas A. Triscaridirector
Questions about BMTM
Answered from the filings on this page, as of the latest one.
Are insiders buying BMTM?
No. In the last 90 days no insider at Bright Mountain Media, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BMTM on the open market?
No open-market trade has been scored at Bright Mountain Media, Inc.. The latest Form 4 on file was filed on May 19, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Bright Mountain Media, Inc.?
7 people have filed a Form 4 at Bright Mountain Media, Inc., among them Matthew Drinkwater (Chief Executive Officer), Jeffrey K. Hirsch (director), Ari Roy Olgun (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.